Most cited papers from PharmaIN (United States)

PharmaIN (United States)

What are the most cited papers from PharmaIN (United States)?

The most cited paper from PharmaIN (United States) is "Melanoidin, a Food Protein‐Derived Advanced Maillard Reaction Product, Suppresses Helicobacter pylori in vitro and in vivo" (Shigeru Hiramoto, Kazuro Itoh, Satomi Shizuuchi et al., 2004), with 63 citations. Next come "Noninvasive Magnetic Resonance Imaging of Microvascular Changes in Type 1 Diabetes" (53) and "Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs" (29).

Published TypeFieldAccess

Showing 19 of 19 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Melanoidin, a Food Protein‐Derived Advanced Maillard Reaction Product, Suppresses Helicobacter pylori in vitro and in vivo Shigeru Hiramoto, Kazuro Itoh, Satomi Shizuuchi et al. · Helicobacter	9 Sep 2004	63
2	Noninvasive Magnetic Resonance Imaging of Microvascular Changes in Type 1 Diabetes Zdravka O. Medarova, G. Castillo, Guangping Dai et al. · Diabetes Open access	5 Sep 2007	53
3	Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs Alexei A. Bogdanov Jr, Mary L. Mazzanti, Gerardo M. Castillo et al. · Theranostics Open access	2012	29
4	Effects of catechin-rich green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells Kensuke Yasui, Hiroki Tanabe, Norihisa Okada et al. · Biomedical Research Open access	2010	20
5	The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: Assessment of receptor contribution Beverly A. Teicher, Hans-Peter Biemann, George Vande Woude et al. · International Journal of Oncology Open access	Apr 2008	18
6	Extending Residence Time and Stability of Peptides by Protected Graft Copolymer (PGC) Excipient: GLP-1 Example Gerardo M. Castillo, Sandra Reichstetter, Elijah M. Bolotin · Pharmaceutical Research Open access	4 Aug 2011	15
7	Imaging the pancreatic vasculature in diabetes models Zdravka O. Medarova, Dale L. Greiner, Marytheresa A. Ifediba et al. · Diabetes/Metabolism Research and Reviews Open access	Nov 2011	13
8	Identification of Dimethylmatairesinol as an Immunoglobulin E-suppressing Component of the Leaves of Cinnamomum camphora Hiroki Tanabe, Ryuuta Fukutomi, Kensuke Yasui et al. · Eisei kagaku Open access	2011	12
9	Omeprazole and PGC-Formulated Heparin Binding Epidermal Growth Factor Normalizes Fasting Blood Glucose and Suppresses Insulitis in Multiple Low Dose Streptozotocin Diabetes Model Gerardo M. Castillo, Akiko Nishimoto-Ashfield, Aryamitra A. Banerjee et al. · Pharmaceutical Research Open access	20 Jun 2013	9
10	Protected Graft Copolymer (PGC) Basal Formulation of Insulin as Potentially Safer Alternative to Lantus® (Insulin-Glargine): A Streptozotocin-Induced, Diabetic Sprague Dawley Rats Study Sandra Reichstetter, Gerardo M. Castillo, Manshun Lai et al. · Pharmaceutical Research	27 Dec 2011	8
11	Hydrophobic-core PEGylated graft copolymer-stabilized nanoparticles composed of insoluble non-nucleoside reverse transcriptase inhibitors exhibit strong anti-HIV activity Anita M. Leporati, Mikhail Sergeevich Novikov, Vladimir T. Valuev-Elliston et al. · Nanomedicine Nanotechnology Biology and Medicine Open access	26 Jul 2016	7
12	Effects of Short-Term Intake of Wheat Bran with Different Particle Sizes on the Murine Intestinal Environment Katsuki Iwai, Yuko Yoshikawa, Noriyuki Miyoshi et al. · Food Science and Technology Research Open access	2017	4
13	Protected graft copolymer-formulated fibroblast growth factors mitigate the lethality of partial body irradiation injury Gerardo M. Castillo, Akiko Nishimoto-Ashfield, Cynthia C. Jones et al. · PLoS ONE Open access	16 Feb 2017	4
14	Protected Graft Copolymer Excipient Leads to a Higher Acute Maximum Tolerated Dose and Extends Residence Time of Vasoactive Intestinal Peptide Significantly Better than Sterically Stabilized Micelles Sandra Reichstetter, Gerardo M. Castillo, Israel Rubinstein et al. · Pharmaceutical Research Open access	6 Dec 2012	3
15	PA YEAST SC-1, Polyamine-Rich Saccharomyces cerevisiae, Induces Muscle Hypertrophy in C2C12 Myotubes Yasukiyo Yoshioka, K Onishi, Kensuke Yasui et al. · Journal of Nutritional Science and Vitaminology Open access	28 Feb 2024	2
16	Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist Gerardo M. Castillo, Yao Yao, Rebecca E. Guerra et al. · Biomedicine & Pharmacotherapy Open access	3 Jan 2024	1
17	Additional file 1 of Efficacy and safety of SP16 in preventing acute kidney injury in at-risk subjects with chronic kidney disease undergoing elective cardiac surgery using the heart–lung-machine (EASE-AKI): study protocol for a prospective, randomised, double-blind, placebo-controlled clinical trial Tilman Jobst‐Schwan, Karl Bihlmaier, Dana Austin et al. · Figshare Open access	28 Aug 2026	0
18	Clinical exploration of safety and efficacy of Polyherbal oil as a topical application in Diabetic non healing wounds and ulcers compared with Betadine10% ointment Milind Gharpure, Nikhil Varma, Gopal Rao et al. · Research Square PreprintOpen access	7 Jun 2022	0
19	IMMUNOSUPPRESSION BY A HUMAN ANTI-CD40 MAB, 4D11, IS NOT ABROGATED WHEN COMBINED WITH TACROLIMUS ON CYNOMORGUS MONKEY RENAL TRANSPLANTATION. M. Uno, Kazuo Yamashita, T Suzuki et al. · Transplantation	27 Jul 2008	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.